摘要
目的:探讨辛伐他汀对急性缺血性脑血管病超敏C反应蛋白(Hs-CRP)的影响。方法:将我科近3年来住院的急性缺血性脑血管病患者110例随机分为两组,两组患者均进行常规调节血压、血糖、抗凝、抗血小板、改善微循环及脑保护等治疗,研究组在此基础上加辛伐他汀(舒降之)20mg/d。结果:急性缺血性脑血管病患者的血清Hs-CRP均有不同程度的升高。经过治疗,研究组和对照组的血清Hs-CRP均有下降,但研究组下降更明显,两组相比有统计学意义。结论:辛伐他汀可以降低缺血性脑血管病的Hs-CRP。
Objective：To discuss the effect of simvastatin on high sensitivity C-reaction protein （Hs-CRP）of acute ischemic cerebrovacular disease.Methods：110 patients with acute ischemic cerebrovacular disease admitted to hospital in recent 3 years were divided randomly into two groups,both groups undergoing the routine treatment aimed at regulating blood pressure and blood sugar,resisting blood coagulation and platelet,and improving microcirculation.The experiment group is also given an additional 20 mg/d of simvastatin.Results： Hs-CRP from patients with acute ischemic cerebrovacular disease went more or less higher.After treatment,Hs-CRP from both the experiment group and the controlled group dropped,with more obvious fall in the experiment group,which demonsated a significant difference between the two groups.Conclusion： Simvastatin can bring down Hs-CRP of acute ischemic cerebrovacular disease.
出处
《内蒙古医学杂志》
2010年第10期1202-1204,共3页
Inner Mongolia Medical Journal
